Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Predictors of the Response to Adalimumab in Rheumatoid Arthritis

This study has been completed.
Information provided by (Responsible Party):
University Hospital, Rouen Identifier:
First received: October 5, 2005
Last updated: February 8, 2012
Last verified: February 2012